ENTITY

Gracell Biotechnologies Inc (GRCL US)

Analysis

Health Care • United States

Gracell Biotechnologies Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing cell therapies to address medical needs in the treatment of cancer. Gracell Biotechnologies aims to disrupt conventional approaches to CAR-T cell therapies with technology platforms-FasTCAR and TruUCAR.

Refresh

Company Event • 08 Mar 2024 15:00 • Upcoming

Add To Calendar

Q4 2023

Company Event • 13 Dec 2023 20:00 • Upcoming

Add To Calendar

Corporate Presentation

Company Event • 13 Nov 2023 21:00 • Latest

Q3 2023

Company Event • 01 Nov 2023 20:00 • Upcoming

Add To Calendar

Investor Presentation

Company Event • 26 Sep 2023 19:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00